Limba
|
Garsorasib (D-1553 ) is a potent and selective oral KRASG12Cinhibitor with antitumor activity. It has the potential to treat KRAS G12C-mutated non-small cell lung cancer (NSCLC).
Price | 5.442,00 RON (preturile sunt fara TVA) |
---|---|
Description |
Garsorasib (D-1553 ) is a potent and selective oral KRASG12Cinhibitor with antitumor activity. It has the potential to treat KRAS G12C-mutated non-small cell lung cancer (NSCLC). |